Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06172478
Title	A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Daiichi Sankyo
Indications	cervical adenosquamous carcinoma gastric adenocarcinoma ureter carcinoma castration-resistant prostate carcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma oral squamous cell carcinoma cervical adenocarcinoma endometrial carcinoma renal pelvis carcinoma laryngeal squamous cell carcinoma peritoneum cancer ovarian carcinoma esophagus squamous cell carcinoma bladder urothelial carcinoma ovary epithelial cancer pancreatic adenocarcinoma prostate cancer fallopian tube cancer urethra transitional cell carcinoma oropharynx cancer hypopharynx cancer uterine carcinosarcoma skin melanoma prostate adenocarcinoma acral lentiginous melanoma cervical squamous cell carcinoma
Therapies	Patritumab deruxtecan
Age Groups:	adult \| senior
Covered Countries	USA